Ian Bledsoe, MD

Title(s)Associate Professor, Neurology
SchoolSchool of Medicine
ORCID ORCID Icon0000-0001-8885-8148 Additional info
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences

    Collapse Biography 
    Collapse Education and Training
    Rush University Medical CenterMS2016Clinical Research
    University of Pittsburgh School of MedicineMD2009
    Stanford University Medical CenterResidency2013Neurology
    Stanford University Medical CenterFellowship2014
    Rush University Medical CenterFellowship2016Movement Disorders
    Collapse Awards and Honors
    UCSF2021  - 2022The Cheryl Jay Master Clinician Award for Clinical Excellence in Neurology
    American Academy of Neurology2020  - 2021Jon Stolk Award in Movement Disorders for Young Investigators
    Stanford University2012  - 2013Neurology Clerkship Teaching Award

    Collapse Overview 
    Collapse Overview
    Dr. Ian Bledsoe is a neurologist who cares for patients who have Parkinson's disease, tremors, ataxia, dystonia and other movement disorders. His treatments include medications, botulinum toxin injections and a surgical procedure called deep brain stimulation.

    Bledsoe has a special interest in dystonia, a disorder that causes involuntary movements, cramps and abnormal postures. He particularly focuses on a form of the condition that affects musicians and other patients whose work requires repetitive movements.

    Bledsoe's research interests include finding better treatments for dystonia and using neuroimaging – advanced image-producing technologies applied to the nervous system – to improve understanding of what causes the condition. He has also used neuroimaging to study cognitive problems associated with Parkinson's disease.

    Bledsoe received his medical degree from the University of Pittsburgh School of Medicine. He then completed a residency in neurology as well as a fellowship in clinical neurophysiology and electromyography at Stanford Health Care. At Rush University Medical Center in Chicago, he also completed a fellowship in movement disorders and a master's degree in clinical research.

    Bledsoe is a member of the American Academy of Neurology, International Parkinson and Movement Disorder Society, and Performing Arts Medicine Association.

    Before attending medical school, Bledsoe earned a bachelor's degree in violin performance at Northwestern University. He continues to play and perform in his free time.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Functional Imaging of Deep Brain Stimulation in Dystonia: A Review. Dystonia. 2023; 2:11440. Bledsoe IO, Morrison M.
    2. Parkinsonism of uncertain clinical significance (PUCS): A proposed new diagnostic entity. J Neurol Sci. 2023 08 15; 451:120696. Zitser J, Brown EG, Ostrem JL, Tanner CM, Rowe JB, Nguyen V, Rosen H, Geschwind MD, Bledsoe IO. PMID: 37352617.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Functional Impairment Preceding Parkinson Disease Diagnosis-What's in a Prodrome? JAMA Neurol. 2023 02 01; 80(2):130-132. Bledsoe IO, Yu J, Shukla AW. PMID: 36534382.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Enhancing Clinical Information Display to Improve Patient Encounters: Human-Centered Design and Evaluation of the Parkinson Disease-BRIDGE Platform. JMIR Hum Factors. 2022 May 06; 9(2):e33967. Brown EG, Schleimer E, Bledsoe IO, Rowles W, Miller NA, Sanders SJ, Rankin KP, Ostrem JL, Tanner CM, Bove R. PMID: 35522472; PMCID: PMC9123539.
      View in: PubMed   Mentions: 1     Fields:    
    5. Prefrontal Physiomarkers of Anxiety and Depression in Parkinson's Disease. Front Neurosci. 2021; 15:748165. de Hemptinne C, Chen W, Racine CA, Seritan AL, Miller AM, Yaroshinsky MS, Wang SS, Gilron R, Little S, Bledsoe I, San Luciano M, Katz M, Chang EF, Dawes HE, Ostrem JL, Starr PA. PMID: 34744613; PMCID: PMC8568318.
      View in: PubMed   Mentions: 8  
    6. Paraneoplastic Syndrome Associated with Kelch-Like Protein 11 Antibodies Presenting with Progressive Ataxia and Tremor. Mov Disord Clin Pract. 2021 Aug; 8(Suppl 1):S42-S44. Prakash P, Bledsoe IO. PMID: 34514048; PMCID: PMC8414488.
      View in: PubMed   Mentions: 2     Fields:    
    7. Commentary: Paraneoplastic Syndrome Associated with Kelch-Like Protein 11 Antibodies Presenting with Progressive Ataxia and Tremor. Mov Disord Clin Pract. 2021 Aug; 8(Suppl 1):S45-S46. Fasano A, Prakash P, Bledsoe IO, Balint B. PMID: 34514049; PMCID: PMC8414493.
      View in: PubMed   Mentions:    Fields:    
    8. Embedded adaptive deep brain stimulation for cervical dystonia controlled by motor cortex theta oscillations. Exp Neurol. 2021 11; 345:113825. Johnson V, Wilt R, Gilron R, Anso J, Perrone R, Beudel M, Piña-Fuentes D, Saal J, Ostrem JL, Bledsoe I, Starr P, Little S. PMID: 34331900.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    9. Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson's disease. Nat Biotechnol. 2021 09; 39(9):1078-1085. Gilron R, Little S, Perrone R, Wilt R, de Hemptinne C, Yaroshinsky MS, Racine CA, Wang SS, Ostrem JL, Larson PS, Wang DD, Galifianakis NB, Bledsoe IO, San Luciano M, Dawes HE, Worrell GA, Kremen V, Borton DA, Denison T, Starr PA. PMID: 33941932; PMCID: PMC8434942.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    10. Twelve Drummers Drumming… With Dystonia. Tremor Other Hyperkinet Mov (N Y). 2021 02 08; 11:6. Bledsoe IO, Reich SG, Frucht SJ, Goldman JG. PMID: 33633869; PMCID: PMC7894364.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Thalamic deep brain stimulation for acquired dystonia in children and young adults: a phase 1 clinical trial. J Neurosurg Pediatr. 2020 Nov 27; 27(2):203-212. San Luciano M, Robichaux-Viehoever A, Dodenhoff KA, Gittings ML, Viser AC, Racine CA, Bledsoe IO, Watson Pereira C, Wang SS, Starr PA, Ostrem JL. PMID: 33254134; PMCID: PMC8155109.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    12. Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation. Neurotherapeutics. 2020 10; 17(4):1622-1644. Bledsoe IO, Viser AC, San Luciano M. PMID: 33095402; PMCID: PMC7851280.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    13. Medical education in movement disorders during the COVID-19 pandemic. Parkinsonism Relat Disord. 2020 08; 77:11-12. Zuzuárregui JRP, Bledsoe IO, Brown EG, Dietiker CG, Galifianakis NB. PMID: 32570192; PMCID: PMC7295506.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    14. FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia. Toxins (Basel). 2020 05 17; 12(5). Spiegel LL, Ostrem JL, Bledsoe IO. PMID: 32429600; PMCID: PMC7290737.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    15. Phenomenology of Muscle Spasms in Satoyoshi Syndrome and Treatment With Botulinum Toxin Injections. Mov Disord Clin Pract. 2020 Jul; 7(5):555-556. Bledsoe IO. PMID: 32626802; PMCID: PMC7328425.
      View in: PubMed   Mentions:    Fields:    
    16. Phenomenology and Management of Subthalamic Stimulation-Induced Dyskinesia in Patients With Isolated Dystonia. Mov Disord Clin Pract. 2020 Jul; 7(5):548-551. Bledsoe IO, Dodenhoff KA, San Luciano M, Volz MM, Starr PA, Markun LC, Ostrem JL. PMID: 32626800; PMCID: PMC7328432.
      View in: PubMed   Mentions: 2     Fields:    
    17. Cerebellar Deep Brain Stimulation for Acquired Hemidystonia. Mov Disord Clin Pract. 2020 Feb; 7(2):188-193. Brown EG, Bledsoe IO, Luthra NS, Miocinovic S, Starr PA, Ostrem JL. PMID: 32071938; PMCID: PMC7011833.
      View in: PubMed   Mentions: 17     Fields:    
    18. Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis. N Engl J Med. 2019 07 04; 381(1):47-54. Mandel-Brehm C, Dubey D, Kryzer TJ, O'Donovan BD, Tran B, Vazquez SE, Sample HA, Zorn KC, Khan LM, Bledsoe IO, McKeon A, Pleasure SJ, Lennon VA, DeRisi JL, Wilson MR, Pittock SJ. PMID: 31269365; PMCID: PMC6800027.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    19. White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease. Neurology. 2018 12 11; 91(24):e2244-e2255. Bledsoe IO, Stebbins GT, Merkitch D, Goldman JG. PMID: 30429273; PMCID: PMC6329325.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    20. Movement disorder society criteria for clinically established early Parkinson's disease. Mov Disord. 2018 10; 33(10):1643-1646. Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-Romenets S, Schäffer E, Seppi K, Heim B, Slow E, Stern M, Bledsoe IO, Deuschl G, Postuma RB. PMID: 30145841.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    21. Validation of the MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2018 10; 33(10):1601-1608. Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D. PMID: 30145797.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    22. Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease. Neurology. 2017 Mar 28; 88(13):1265-1272. Goldman JG, Bledsoe IO, Merkitch D, Dinh V, Bernard B, Stebbins GT. PMID: 28235816; PMCID: PMC5373777.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    23. Botulinum Toxin Treatment of Cervical Dystonia. Semin Neurol. 2016 Feb; 36(1):47-53. Bledsoe IO, Comella CL. PMID: 26866496.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    24. Oculomotor assessments of executive function in preterm children. J Pediatr. 2012 Sep; 161(3):427-433.e1. Loe IM, Luna B, Bledsoe IO, Yeom KW, Fritz BL, Feldman HM. PMID: 22480696; PMCID: PMC3638733.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    Ian's Networks
    Concepts (90)
    Derived automatically from this person's publications.
    Co-Authors (24)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department